Maoqiang Li

853 total citations
36 papers, 677 citations indexed

About

Maoqiang Li is a scholar working on Molecular Biology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Maoqiang Li has authored 36 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Surgery and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Maoqiang Li's work include Orthopaedic implants and arthroplasty (5 papers), Inflammasome and immune disorders (5 papers) and MicroRNA in disease regulation (4 papers). Maoqiang Li is often cited by papers focused on Orthopaedic implants and arthroplasty (5 papers), Inflammasome and immune disorders (5 papers) and MicroRNA in disease regulation (4 papers). Maoqiang Li collaborates with scholars based in China and United States. Maoqiang Li's co-authors include Wu Jiang, Fan He, Xuepeng Wang, Liulong Zhu, Zhenyu Bian, Shaobo Zhou, Chunming Jiang, Kongzu Hu, Zhanchun Li and Jie Xiao and has published in prestigious journals such as International Journal of Molecular Sciences, Spine and Gene.

In The Last Decade

Maoqiang Li

32 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maoqiang Li China 16 396 174 114 87 77 36 677
Wu Jiang China 14 383 1.0× 207 1.2× 63 0.6× 45 0.5× 78 1.0× 25 671
Fei Lan China 19 469 1.2× 75 0.4× 148 1.3× 57 0.7× 76 1.0× 35 910
Haoli Wang China 16 372 0.9× 270 1.6× 90 0.8× 73 0.8× 49 0.6× 31 792
Xinghui Song China 18 305 0.8× 120 0.7× 63 0.6× 133 1.5× 77 1.0× 45 781
Jiwei Cheng China 14 242 0.6× 173 1.0× 88 0.8× 158 1.8× 55 0.7× 39 629
Minfei Wu China 12 345 0.9× 92 0.5× 69 0.6× 56 0.6× 63 0.8× 17 549
Giovanna Giuseppina Altobelli Italy 14 418 1.1× 80 0.5× 81 0.7× 97 1.1× 47 0.6× 27 858
Zhiwen Song China 16 294 0.7× 148 0.9× 98 0.9× 59 0.7× 58 0.8× 35 652

Countries citing papers authored by Maoqiang Li

Since Specialization
Citations

This map shows the geographic impact of Maoqiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maoqiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maoqiang Li more than expected).

Fields of papers citing papers by Maoqiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maoqiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maoqiang Li. The network helps show where Maoqiang Li may publish in the future.

Co-authorship network of co-authors of Maoqiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Maoqiang Li. A scholar is included among the top collaborators of Maoqiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maoqiang Li. Maoqiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhen, et al.. (2025). Urolithin a attenuates rheumatoid arthritis by inhibiting inflammation and pyroptosis in fibroblasts via the AMPK/ NF-κB signaling pathway. International Immunopharmacology. 155. 114604–114604. 4 indexed citations
2.
Lu, Congcong, et al.. (2024). LINC00665 aggravates the malignant phenotypes in chondrosarcoma cells through miR-665/FGF9 pathway. International Journal of Biological Macromolecules. 280(Pt 1). 135727–135727.
3.
Wang, Xuepeng, et al.. (2024). POU Class 2 Homeobox Associating Factor 1, as a Hub Candidate Gene in OP, Relieves Osteoblast Apoptosis. Applied Biochemistry and Biotechnology. 196(9). 6072–6096.
4.
Xie, Shujun, Lingqiao Wang, Lili Yan, et al.. (2023). Targeting macrophagic PIM-1 alleviates osteoarthritis by inhibiting NLRP3 inflammasome activation via suppressing mitochondrial ROS/Cl− efflux signaling pathway. Journal of Translational Medicine. 21(1). 452–452. 19 indexed citations
5.
Li, Maoqiang, et al.. (2023). Distal forearm squeeze test for the diagnosis of digital flexor tendon injuries. BMC Musculoskeletal Disorders. 24(1). 975–975.
6.
Li, Maoqiang, et al.. (2021). Investigation of Low‐Frequency Sound Radiation Characteristics and Active Control Mechanism of a Finite Cylindrical Shell. Shock and Vibration. 2021(1). 2 indexed citations
7.
Wang, Xuepeng, et al.. (2020). Neuropilin and tolloid-like 2 regulates the progression of osteosarcoma. Gene. 768. 145292–145292. 5 indexed citations
8.
Chen, Yun, et al.. (2018). Design and experimental validation of improved grapevine burying machine. International journal of agricultural and biological engineering. 11(2). 95–100. 1 indexed citations
9.
Chen, Yun, et al.. (2018). Design and experimental validation of improved grapevine burying machine. International journal of agricultural and biological engineering. 11(2). 95–100. 3 indexed citations
10.
Jiang, Wu, Maoqiang Li, Fan He, & Liulong Zhu. (2018). Inhibition of NLRP3 inflammasome attenuates spinal cord injury‐induced lung injury in mice. Journal of Cellular Physiology. 234(5). 6012–6022. 15 indexed citations
11.
Jiang, Chunming, Shenglin Ma, Xuepeng Wang, et al.. (2018). Effect of CXCR4 on Apoptosis in Osteosarcoma Cells via the PI3K/Akt/NF-κβ Signaling Pathway. Cellular Physiology and Biochemistry. 46(6). 2250–2260. 34 indexed citations
12.
Wang, Xuepeng, et al.. (2018). Paravertebral injection of botulinum toxin‐A reduces lumbar vertebral bone quality. Journal of Orthopaedic Research®. 36(10). 2664–2670. 2 indexed citations
13.
Zhang, Hongxu, Chunming Jiang, Maoqiang Li, et al.. (2017). CXCR4 enhances invasion and proliferation of bone marrow stem cells via PI3K/AKT/NF-κB signaling pathway.. PubMed. 10(9). 9829–9836. 8 indexed citations
14.
Li, Maoqiang, et al.. (2017). 11R-VIVIT Peptide Inhibits Calvaria Osteolysis Induced by Experimental Design. Journal of Craniofacial Surgery. 28(2). 570–573.
15.
Xiao, Jie, Weifeng Yu, Kongzu Hu, et al.. (2017). miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway. Oncology Reports. 37(4). 2513–2521. 37 indexed citations
16.
Jiang, Wu, Maoqiang Li, Fan He, et al.. (2016). Neuroprotective effect of asiatic acid against spinal cord injury in rats. Life Sciences. 157. 45–51. 55 indexed citations
17.
Jiang, Wu, Maoqiang Li, Fan He, et al.. (2016). Rutin attenuates neuroinflammation in spinal cord injury rats. Journal of Surgical Research. 203(2). 331–337. 47 indexed citations
19.
Li, Maoqiang, Zhenan Zhu, & Fengxiang Liu. (2010). Effect of blockade of calcineurin/nuclear factor of activated T cells paths by VIVIT peptide on inhibition of osteoprogenitor differentiation by polymethylmethacrylate particles. Zhonghua chuangshang guke zazhi. 12(2). 156–161. 1 indexed citations
20.
Li, Maoqiang, Fengxiang Liu, Gang Wang, et al.. (2010). Enhancement of osteoblast differentiation that is inhibited by titanium particles through inactivation of NFATc1 by VIVIT peptide. Journal of Biomedical Materials Research Part A. 95A(3). 727–734. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026